Publication | Closed Access

Impact of serum hepcidin and inflammatory markers on resistance to erythropoiesis-stimulating therapy in haemodialysis patients

InflammationHemodialysisRenal FunctionChronic Kidney DiseaseImmunologyHematologyDialysis TherapyInflammatory MarkersSerum HepcidinMedicineHaemodialysis PatientsNephrologyHepcidin